Effectiveness of Tocilizumab in Patients Hospitalized With COVID-19: A Follow-up of the CORIMUNO-TOCI-1 Randomized Clinical Trial.
in JAMA internal medicine,
2021-09-01; Vol. 181 (9) ( pmid :
Parietal epithelial cell dysfunction in crescentic glomerulonephritis.
in Cell and tissue research,
2021-08-28; Vol. ( pmid :
Autoantibodies neutralizing type I IFNs are present in 4% of uninfected individuals over 70 years old and account for 20% of COVID-19 deaths.
in Science immunology,
2021-08-19; Vol. 6 (62) ( pmid :
Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs.
in The Journal of clinical investigation,
2021-06-01; Vol. 131 (11) ( pmid :
Calpastatin prevents Angiotensin II-mediated podocyte injury through maintenance of autophagy.
in Kidney international,
2021-03-03; Vol. ( pmid :